MultiPark: Multidisciplinary research focused on Parkinson´s disease
3351 – 3360 of 3882
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain
(
- Contribution to journal › Scientific review
-
Mark
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia.
(
- Contribution to journal › Article
-
Mark
Label-free somatic cell cytometry in raw milk using acoustophoresis.
(
- Contribution to journal › Article
-
Mark
Novel disease-specific promoters for use in gene therapy for Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients.
(
- Contribution to journal › Article
-
Mark
alpha-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease.
(
- Contribution to journal › Scientific review
-
Mark
Genetics of Parkinson's
2012) p.88-90(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Medical need, ethical scepticism: clashing views on the use of fœtuses in Parkinson’s disease research
2012)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The Body as a Societal Resource in Transnational Giving: The Organ-Exchange Organizations of Scandiatransplant and Balttransplant
2012) p.204-234(
- Chapter in Book/Report/Conference proceeding › Book chapter